nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties
|
Hochepied, Tino |
|
2003 |
71-72 |
1 |
p. 25-34 10 p. |
artikel |
2 |
Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL
|
Sattler, Martin |
|
1997 |
71-72 |
1 |
p. 63-79 17 p. |
artikel |
3 |
Adiponectin: A biomarker for rheumatoid arthritis?
|
Chen, Xiuping |
|
2013 |
71-72 |
1 |
p. 83-89 7 p. |
artikel |
4 |
Alternate signalling pathways from the interleukin-2 receptor
|
Ellery, Jonathan M. |
|
2002 |
71-72 |
1 |
p. 27-40 14 p. |
artikel |
5 |
A new partner for inhibitory Smads
|
Miyazono, Kohei |
|
2002 |
71-72 |
1 |
p. 7-9 3 p. |
artikel |
6 |
An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17
|
Grine, Lynda |
|
2015 |
71-72 |
1 |
p. 25-33 9 p. |
artikel |
7 |
Announcement
|
|
|
1996 |
71-72 |
1 |
p. 113- 1 p. |
artikel |
8 |
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders
|
Yang, Yang |
|
2015 |
71-72 |
1 |
p. 47-57 11 p. |
artikel |
9 |
Antiviral defense: RIG-Ing the immune system to STING
|
Bowzard, J. Bradford |
|
2009 |
71-72 |
1 |
p. 1-5 5 p. |
artikel |
10 |
Bone morphogenetic proteins: An unconventional approach to isolation of first mammalian morphogens
|
Reddi, A Hari |
|
1997 |
71-72 |
1 |
p. 11-20 10 p. |
artikel |
11 |
Book review
|
|
|
1998 |
71-72 |
1 |
p. 89-90 2 p. |
artikel |
12 |
Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor gp130 dependent pathways
|
Pennica, Diane |
|
1996 |
71-72 |
1 |
p. 81-91 11 p. |
artikel |
13 |
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
|
Zhang, Jian |
|
2010 |
71-72 |
1 |
p. 41-48 8 p. |
artikel |
14 |
CD100/Sema4D, a lymphocyte semaphorin involved in the regulation of humoral and cellular immune responses
|
Suzuki, Kazuhiro |
|
2003 |
71-72 |
1 |
p. 17-24 8 p. |
artikel |
15 |
Characterization and potential clinical applications of autoantibodies against cytokines
|
de Lemos Rieper, Carina |
|
2009 |
71-72 |
1 |
p. 61-75 15 p. |
artikel |
16 |
Chemokine receptors: Structure, function and role in microbial pathogenesis
|
Murphy, Philip M |
|
1996 |
71-72 |
1 |
p. 47-64 18 p. |
artikel |
17 |
Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12
|
Singh, Anup Kumar |
|
2013 |
71-72 |
1 |
p. 41-49 9 p. |
artikel |
18 |
Chemokines in immune-mediated inflammation of the central nervous system
|
Ransohoff, Richard M |
|
1996 |
71-72 |
1 |
p. 35-46 12 p. |
artikel |
19 |
conference calendar
|
|
|
2003 |
71-72 |
1 |
p. 83- 1 p. |
artikel |
20 |
Conference calendar
|
|
|
1996 |
71-72 |
1 |
p. 119-120 2 p. |
artikel |
21 |
Conference calendar
|
|
|
1997 |
71-72 |
1 |
p. 99-100 2 p. |
artikel |
22 |
Conference calendar
|
|
|
2005 |
71-72 |
1 |
p. V-VI nvt p. |
artikel |
23 |
Conference calendar
|
|
|
2004 |
71-72 |
1 |
p. 81-82 2 p. |
artikel |
24 |
Conference Calender
|
|
|
2002 |
71-72 |
1 |
p. 91- 1 p. |
artikel |
25 |
Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands
|
Horowitz, Mark C |
|
2001 |
71-72 |
1 |
p. 9-18 10 p. |
artikel |
26 |
Corrigendum to “The tale of soluble receptors and binding proteins: From bench to bedside” [Cytokine Growth Factor Rev. 18 (2007) 525–33]
|
Novick, Daniela |
|
2008 |
71-72 |
1 |
p. 109- 1 p. |
artikel |
27 |
CXCR3, CXCL10 and type 1 diabetes
|
Antonelli, Alessandro |
|
2014 |
71-72 |
1 |
p. 57-65 9 p. |
artikel |
28 |
Cytokine and cytokine receptor gene polymorphisms and their functionality
|
Smith, Andrew J.P. |
|
2009 |
71-72 |
1 |
p. 43-59 17 p. |
artikel |
29 |
Cytokine and Growth Factor Reviews to be published six times a year
|
Sporn, Michael |
|
2002 |
71-72 |
1 |
p. 1-2 2 p. |
artikel |
30 |
Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis
|
Avau, Anneleen |
|
2015 |
71-72 |
1 |
p. 35-45 11 p. |
artikel |
31 |
Cytokine regulation of cellular adhesion molecule expression in inflammation
|
Meager, A. |
|
1999 |
71-72 |
1 |
p. 27-39 13 p. |
artikel |
32 |
Cytokines, dendritic cells and immunological rejection
|
Ferrantini, Maria |
|
2008 |
71-72 |
1 |
p. 1-2 2 p. |
artikel |
33 |
Cytokines in 1995
|
Vilĉek, Jan T. |
|
1996 |
71-72 |
1 |
p. 103-106 4 p. |
artikel |
34 |
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
|
Grivennikov, Sergei I. |
|
2010 |
71-72 |
1 |
p. 11-19 9 p. |
artikel |
35 |
Dendritic cells and cytokines in human inflammatory and autoimmune diseases
|
Blanco, Patrick |
|
2008 |
71-72 |
1 |
p. 41-52 12 p. |
artikel |
36 |
Dendritic cells and cytokines in immune rejection of cancer
|
Ferrantini, Maria |
|
2008 |
71-72 |
1 |
p. 93-107 15 p. |
artikel |
37 |
Dendritic cells and innate defense against tumor cells
|
Ullrich, Evelyn |
|
2008 |
71-72 |
1 |
p. 79-92 14 p. |
artikel |
38 |
Discussion
|
|
|
1998 |
71-72 |
1 |
p. 85-87 3 p. |
artikel |
39 |
Distinctive features of Trk neurotrophin receptor transactivation by G protein-coupled receptors
|
Lee, Francis S. |
|
2002 |
71-72 |
1 |
p. 11-17 7 p. |
artikel |
40 |
Does cytokine signaling link sphingolipid metabolism to host defense and immunity against virus infections?
|
Seo, Young-Jin |
|
2011 |
71-72 |
1 |
p. 55-61 7 p. |
artikel |
41 |
Dominance of the strongest: Inflammatory cytokines versus glucocorticoids
|
Dejager, Lien |
|
2014 |
71-72 |
1 |
p. 21-33 13 p. |
artikel |
42 |
Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor
|
Nanba, Daisuke |
|
2004 |
71-72 |
1 |
p. 13-19 7 p. |
artikel |
43 |
Dual role for TGF-β1 in apoptosis
|
Sánchez-Capelo, Amelia |
|
2005 |
71-72 |
1 |
p. 15-34 20 p. |
artikel |
44 |
Editorial Board
|
|
|
2009 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
45 |
Editorial Board
|
|
|
2010 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
46 |
Editorial Board
|
|
|
1996 |
71-72 |
1 |
p. IFC- 1 p. |
artikel |
47 |
Editorial Board
|
|
|
1997 |
71-72 |
1 |
p. IFC- 1 p. |
artikel |
48 |
Editorial Board
|
|
|
2008 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
49 |
Editorial Board
|
|
|
2011 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
50 |
Editorial Board
|
|
|
2013 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
51 |
Editorial Board and Publication information
|
|
|
2014 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
52 |
Editorial Board and Publication information
|
|
|
2015 |
71-72 |
1 |
p. IFC- 1 p. |
artikel |
53 |
Editorial Board/Publication info
|
|
|
2003 |
71-72 |
1 |
p. IFC- 1 p. |
artikel |
54 |
Editorial Board/Publication info.
|
|
|
2005 |
71-72 |
1 |
p. CO2- 1 p. |
artikel |
55 |
Editorial Board/Publication info.
|
|
|
2004 |
71-72 |
1 |
p. IFC- 1 p. |
artikel |
56 |
Emerging role of interleukin-22 in autoimmune diseases
|
Pan, Hai-Feng |
|
2013 |
71-72 |
1 |
p. 51-57 7 p. |
artikel |
57 |
Eph receptor tyrosine kinases in cancer stem cells
|
Chen, Jin |
|
2015 |
71-72 |
1 |
p. 1-6 6 p. |
artikel |
58 |
Expression profiling in knockout mice: lymphotoxin versus tumor necrosis factor in the maintenance of splenic microarchitecture
|
Shakhov, Alexander N |
|
2001 |
71-72 |
1 |
p. 107-119 13 p. |
artikel |
59 |
Extracellular regulation of VEGF: Isoforms, proteolysis, and vascular patterning
|
Vempati, Prakash |
|
2014 |
71-72 |
1 |
p. 1-19 19 p. |
artikel |
60 |
Facts and Faces
|
|
|
2002 |
71-72 |
1 |
p. 87-89 3 p. |
artikel |
61 |
Facts and faces
|
|
|
2001 |
71-72 |
1 |
p. 127- 1 p. |
artikel |
62 |
Facts and faces
|
|
|
2001 |
71-72 |
1 |
p. 121-125 5 p. |
artikel |
63 |
Facts and faces
|
|
|
1996 |
71-72 |
1 |
p. 115-118 4 p. |
artikel |
64 |
Facts and faces
|
|
|
1997 |
71-72 |
1 |
p. 97- 1 p. |
artikel |
65 |
FLT3: Receptor and Ligand. Biology and Potential Clinical Application
|
Shurin, Michael R |
|
1998 |
71-72 |
1 |
p. 37-48 12 p. |
artikel |
66 |
Foreword
|
Balkwill, Frances |
|
2010 |
71-72 |
1 |
p. 1- 1 p. |
artikel |
67 |
Genetic and biochemical analysis of TGFβ signal transduction
|
Padgett, Richard W |
|
1997 |
71-72 |
1 |
p. 1-9 9 p. |
artikel |
68 |
Heart-specific expression of FGF-16 and a potential role in postnatal cardioprotection
|
Wang, Jie |
|
2015 |
71-72 |
1 |
p. 59-66 8 p. |
artikel |
69 |
Hematopoietic growth factor mimetics: From concept to clinic
|
Perugini, Michelle |
|
2009 |
71-72 |
1 |
p. 87-94 8 p. |
artikel |
70 |
IFN regulation and functions in myeloid dendritic cells
|
Coccia, Eliana Marina |
|
2008 |
71-72 |
1 |
p. 21-32 12 p. |
artikel |
71 |
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology
|
Steeve, Kwan Tat |
|
2004 |
71-72 |
1 |
p. 49-60 12 p. |
artikel |
72 |
Index
|
|
|
1999 |
71-72 |
1 |
p. VII- 1 p. |
artikel |
73 |
Index
|
|
|
1999 |
71-72 |
1 |
p. V- 1 p. |
artikel |
74 |
Inducible nitric oxide synthase activation by interleukin-17
|
Miljkovic, Djordje |
|
2004 |
71-72 |
1 |
p. 21-32 12 p. |
artikel |
75 |
Infection and cancer: the common vein
|
Thomas-Tikhonenko, Andrei |
|
2003 |
71-72 |
1 |
p. 67-77 11 p. |
artikel |
76 |
Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation
|
Mohty, Mohamad |
|
2008 |
71-72 |
1 |
p. 53-63 11 p. |
artikel |
77 |
Insulin-like growth factor binding proteins and their role in controlling IGF actions
|
Clemmons, David R |
|
1997 |
71-72 |
1 |
p. 45-62 18 p. |
artikel |
78 |
Insulin-like growth factor-1 (IGF-1) and growth hormone (GH) in immunity and inflammation
|
Heemskerk, Vincent H |
|
1999 |
71-72 |
1 |
p. 5-14 10 p. |
artikel |
79 |
Interferon-γ in autoimmunity
|
Billiau, Alfons |
|
1996 |
71-72 |
1 |
p. 25-34 10 p. |
artikel |
80 |
Interferons and cytokines on a grand scale
|
Balkwill, Fran |
|
1997 |
71-72 |
1 |
p. 91-95 5 p. |
artikel |
81 |
Interferons in 1995
|
Pfeffer, Lawrence M. |
|
1996 |
71-72 |
1 |
p. 107-111 5 p. |
artikel |
82 |
Interleukin 5 and B cell differentiation
|
Takatsu, Kiyoshi |
|
1998 |
71-72 |
1 |
p. 25-35 11 p. |
artikel |
83 |
Interleukin-6 and prostate cancer progression
|
Smith, Peter C |
|
2001 |
71-72 |
1 |
p. 33-40 8 p. |
artikel |
84 |
Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions
|
Mukaida, Naofumi |
|
1998 |
71-72 |
1 |
p. 9-23 15 p. |
artikel |
85 |
Interleukin-15 is a major regulator of the cell-microenvironment interactions in human renal homeostasis
|
Giron-Michel, Julien |
|
2013 |
71-72 |
1 |
p. 13-22 10 p. |
artikel |
86 |
Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu
|
Nakanishi, Kenji |
|
2001 |
71-72 |
1 |
p. 53-72 20 p. |
artikel |
87 |
Interleukin-15: New kid on the block for antitumor combination therapy
|
Van den Bergh, Johan M.J. |
|
2015 |
71-72 |
1 |
p. 15-24 10 p. |
artikel |
88 |
Interleukin-7: physiological roles and mechanisms of action
|
Hofmeister, R. |
|
1999 |
71-72 |
1 |
p. 41-60 20 p. |
artikel |
89 |
ISGF3γ p48, a specificity switch for interferon activated transcription factors
|
Bluyssen, Hans A.R. |
|
1996 |
71-72 |
1 |
p. 11-17 7 p. |
artikel |
90 |
Kaposi’s sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
|
Ensoli, Barbara |
|
1998 |
71-72 |
1 |
p. 63-83 21 p. |
artikel |
91 |
Ligand-induced dimerization of growth factor receptors: Variations on the theme
|
Heldin, Carl-Henrik |
|
1996 |
71-72 |
1 |
p. 3-10 8 p. |
artikel |
92 |
Lymphocytes in cancer development: Polarization towards pro-tumor immunity
|
Ruffell, Brian |
|
2010 |
71-72 |
1 |
p. 3-10 8 p. |
artikel |
93 |
Matricellular proteins and inflammatory cells: A task force to promote or defeat cancer?
|
Llera, Andrea Sabina |
|
2010 |
71-72 |
1 |
p. 67-76 10 p. |
artikel |
94 |
MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine
|
Sauane, Moira |
|
2003 |
71-72 |
1 |
p. 35-51 17 p. |
artikel |
95 |
Mechanism of BLyS action in B cell immunity
|
Do, Richard Kinh Gian |
|
2002 |
71-72 |
1 |
p. 19-25 7 p. |
artikel |
96 |
MIF, CD74 and other partners in kidney disease: Tales of a promiscuous couple
|
Sanchez-Niño, M.D. |
|
2013 |
71-72 |
1 |
p. 23-40 18 p. |
artikel |
97 |
MIF re-discovered: Pituitary hormone and glucocorticoid-induced regulator of cytokine production
|
Bucala, Richard |
|
1996 |
71-72 |
1 |
p. 19-24 6 p. |
artikel |
98 |
Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis
|
Marchesi, Federica |
|
2010 |
71-72 |
1 |
p. 77-82 6 p. |
artikel |
99 |
MSP: An emerging player in metabolic syndrome
|
Li, Jieyi |
|
2015 |
71-72 |
1 |
p. 75-82 8 p. |
artikel |
100 |
Negative regulation of RelA phosphorylation: Emerging players and their roles in cancer
|
Lu, Xinyuan |
|
2015 |
71-72 |
1 |
p. 7-13 7 p. |
artikel |
101 |
Neurotrophic factors: effects in modulating properties of the neuromuscular endplate
|
Sendtner, Michael |
|
1998 |
71-72 |
1 |
p. 1-7 7 p. |
artikel |
102 |
New perspectives on growth factor-sex steroid interaction in the prostate
|
Ball, Emma M.A |
|
2003 |
71-72 |
1 |
p. 5-16 12 p. |
artikel |
103 |
NF-κB and cell-cycle regulation: the cyclin connection
|
Joyce, David |
|
2001 |
71-72 |
1 |
p. 73-90 18 p. |
artikel |
104 |
NF-κB modulators in osteolytic bone diseases
|
Xu, Jiake |
|
2009 |
71-72 |
1 |
p. 7-17 11 p. |
artikel |
105 |
Non-apoptotic Fas signaling
|
Wajant, Harald |
|
2003 |
71-72 |
1 |
p. 53-66 14 p. |
artikel |
106 |
Pathways mediating VEGF-independent tumor angiogenesis
|
Ferrara, Napoleone |
|
2010 |
71-72 |
1 |
p. 21-26 6 p. |
artikel |
107 |
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history
|
Fitzgerald-Bocarsly, Patricia |
|
2008 |
71-72 |
1 |
p. 3-19 17 p. |
artikel |
108 |
Pleiotropic roles of formyl peptide receptors
|
Le, Yingying |
|
2001 |
71-72 |
1 |
p. 91-105 15 p. |
artikel |
109 |
Proteases and bone remodelling
|
Georges, S. |
|
2009 |
71-72 |
1 |
p. 29-41 13 p. |
artikel |
110 |
Regulation of hepatocyte fate by interferon-γ
|
Horras, Christopher J. |
|
2011 |
71-72 |
1 |
p. 35-43 9 p. |
artikel |
111 |
Regulation of pancreatic function by connective tissue growth factor (CTGF, CCN2)
|
Charrier, Alyssa |
|
2013 |
71-72 |
1 |
p. 59-68 10 p. |
artikel |
112 |
REMOVED: The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction
|
Schlegel, Amnon |
|
2001 |
71-72 |
1 |
p. 41-51 11 p. |
artikel |
113 |
Role of adiponectin in obesity related gastrointestinal carcinogenesis
|
Nagaraju, Ganji Purnachandra |
|
2015 |
71-72 |
1 |
p. 83-93 11 p. |
artikel |
114 |
Role of calprotectin in cardiometabolic diseases
|
Kruzliak, Peter |
|
2014 |
71-72 |
1 |
p. 67-75 9 p. |
artikel |
115 |
Role of IL-15 in immune-mediated and infectious diseases
|
Di Sabatino, Antonio |
|
2011 |
71-72 |
1 |
p. 19-33 15 p. |
artikel |
116 |
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
|
Maulik, Gautam |
|
2002 |
71-72 |
1 |
p. 41-59 19 p. |
artikel |
117 |
Scatter Factors in renal disease: Dr. Jeckyll and Mr. Hyde?
|
Rampino, Teresa |
|
2009 |
71-72 |
1 |
p. 77-85 9 p. |
artikel |
118 |
Signal transduction by bone morphogenetic proteins
|
Kawabata, Masahiro |
|
1998 |
71-72 |
1 |
p. 49-61 13 p. |
artikel |
119 |
Ski/Sno and TGF-β signaling
|
Liu, Xuedong |
|
2001 |
71-72 |
1 |
p. 1-8 8 p. |
artikel |
120 |
Soluble interleukin-1 receptor — reverse signaling in innate immunoregulation
|
Spörri, Bernhard |
|
2001 |
71-72 |
1 |
p. 27-32 6 p. |
artikel |
121 |
Specificity in cytokine signal transduction: lessons learned from the IL-3/IL-5/GM-CSF receptor family
|
Geijsen, Niels |
|
2001 |
71-72 |
1 |
p. 19-25 7 p. |
artikel |
122 |
Sphingosine 1-phosphate, a key mediator of the cytokine network: Juxtacrine signaling
|
Xia, Pu |
|
2011 |
71-72 |
1 |
p. 45-53 9 p. |
artikel |
123 |
Tempting fate: BMP signals for cardiac morphogenesis
|
Schneider, Michael D |
|
2003 |
71-72 |
1 |
p. 1-4 4 p. |
artikel |
124 |
The “bone morphogenic proteins” pathways in bone and joint diseases: Translational perspectives from physiopathology to therapeutic targets
|
Biver, Emmanuel |
|
2013 |
71-72 |
1 |
p. 69-81 13 p. |
artikel |
125 |
The chemokine system in cancer biology and therapy
|
Mantovani, Alberto |
|
2010 |
71-72 |
1 |
p. 27-39 13 p. |
artikel |
126 |
The Class II cytokine receptor (CRF2) family: overview and patterns of receptor–ligand interactions
|
Langer, Jerome A |
|
2004 |
71-72 |
1 |
p. 33-48 16 p. |
artikel |
127 |
The dual role of IL-6-type cytokines on bone remodeling and bone tumors
|
Blanchard, Frédéric |
|
2009 |
71-72 |
1 |
p. 19-28 10 p. |
artikel |
128 |
The ephrins and Eph receptors in angiogenesis
|
Cheng, Nikki |
|
2002 |
71-72 |
1 |
p. 75-85 11 p. |
artikel |
129 |
The ever-increasing complexity of TGF-β signaling
|
Roberts, Anita B. |
|
2002 |
71-72 |
1 |
p. 3-5 3 p. |
artikel |
130 |
The house that JAK/STAT built
|
Levy, David E |
|
1997 |
71-72 |
1 |
p. 81-90 10 p. |
artikel |
131 |
The inauguration of cytokine & growth factor reviews
|
Sporn, Michael B. |
|
1996 |
71-72 |
1 |
p. 1- 1 p. |
artikel |
132 |
The MCP/eotaxin subfamily of CC chemokines
|
Van Coillie, Els |
|
1999 |
71-72 |
1 |
p. 61-86 26 p. |
artikel |
133 |
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle
|
Mocellin, Simone |
|
2004 |
71-72 |
1 |
p. 61-76 16 p. |
artikel |
134 |
The resolution of inflammation and cancer
|
Rodriguez-Vita, Juan |
|
2010 |
71-72 |
1 |
p. 61-65 5 p. |
artikel |
135 |
The role of “anti-inflammatory” cytokines in axon regeneration
|
Vidal, Pía M. |
|
2013 |
71-72 |
1 |
p. 1-12 12 p. |
artikel |
136 |
The role of SATB2 in skeletogenesis and human disease
|
Zhao, Xiaoying |
|
2014 |
71-72 |
1 |
p. 35-44 10 p. |
artikel |
137 |
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer
|
Vandercappellen, Jo |
|
2011 |
71-72 |
1 |
p. 1-18 18 p. |
artikel |
138 |
The role of transforming growth factor (TGF)-β in modulating the immune response and fibrogenesis in the gut
|
Biancheri, Paolo |
|
2014 |
71-72 |
1 |
p. 45-55 11 p. |
artikel |
139 |
The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction
|
Li, Jing |
|
2015 |
71-72 |
1 |
p. 67-74 8 p. |
artikel |
140 |
The transforming growth factor-β superfamily of receptors
|
de Caestecker, Mark |
|
2004 |
71-72 |
1 |
p. 1-11 11 p. |
artikel |
141 |
Thrombopoietin: a pan-hematopoietic cytokine
|
Geddis, Amy E |
|
2002 |
71-72 |
1 |
p. 61-73 13 p. |
artikel |
142 |
TNF receptor associated factors in cytokine signaling
|
Wajant, H |
|
1999 |
71-72 |
1 |
p. 15-26 12 p. |
artikel |
143 |
Transcriptional regulation of vascular endothelial growth factor in cancer
|
Loureiro, Robyn M.B. |
|
2005 |
71-72 |
1 |
p. 77-89 13 p. |
artikel |
144 |
Transcriptional signaling by double-stranded RNA: role of TLR3
|
Sen, Ganes C. |
|
2005 |
71-72 |
1 |
p. 1-14 14 p. |
artikel |
145 |
Transforming growth factor beta (TGF-β) and inflammation in cancer
|
Bierie, Brian |
|
2010 |
71-72 |
1 |
p. 49-59 11 p. |
artikel |
146 |
Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
|
Pepper, Michael S |
|
1997 |
71-72 |
1 |
p. 21-43 23 p. |
artikel |
147 |
Tumor-induced modulation of dendritic cell function
|
Gottfried, Eva |
|
2008 |
71-72 |
1 |
p. 65-77 13 p. |
artikel |
148 |
Tumor necrosis factor, cancer and anticancer therapy
|
Mocellin, Simone |
|
2005 |
71-72 |
1 |
p. 35-53 19 p. |
artikel |
149 |
Tumor suppressor activity of the TGF-β pathway in human cancers
|
Markowitz, Sanford D |
|
1996 |
71-72 |
1 |
p. 93-102 10 p. |
artikel |
150 |
Tumor therapeutics by design: targeting and activation of death receptors
|
Wajant, Harald |
|
2005 |
71-72 |
1 |
p. 55-76 22 p. |
artikel |
151 |
Type I interferon as a stimulus for cross-priming
|
Le Bon, Agnès |
|
2008 |
71-72 |
1 |
p. 33-40 8 p. |
artikel |
152 |
Up and down the growth hormone cascade
|
Clark, Ross G |
|
1996 |
71-72 |
1 |
p. 65-80 16 p. |
artikel |
153 |
Viral chemokine-modulatory proteins: tools and targets
|
Boomker, Jasper M. |
|
2005 |
71-72 |
1 |
p. 91-103 13 p. |
artikel |
154 |
Virus-encoded modulators of cytokines and growth factors
|
Spriggs, Melanie K |
|
1999 |
71-72 |
1 |
p. 1-4 4 p. |
artikel |